Slide 1: IDEX Corporation Fourth Quarter and Full Year 2010 Earnings Release
IDEX Corporation Fourth Quarter and Full Year 2010 Earnings Release February 3, 2011
Slide 2: Agenda
Agenda IDEX Outlook 2010 Summary 2010 Segment Performance Fluid & Metering Health & Science Dispensing Equipment Fire & Safety 2011 Guidance Q&A 2
Slide 3: Replay Information
Replay Information Dial toll-free: 800.642.1687 International: 706.645.9291 Conference ID: #35655677 Log on to: www.idexcorp.com 3
Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act
Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward- looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause thos
Slide 5: IDEX 2010 Financial Performance: Record Revenue and EPS in 2010
Total Revenue Adjusted Operating Margin* Free Cash Flow Adjusted EPS* IDEX 2010 Financial Performance Record Revenue and EPS in 2010 5 *Q4 '10 EPS and Op Margin adjusted for $4.7M of restructuring expense ($3.8M in Q4 '09) / FY 2010 adjusted for $11.1M of restructuring expense ($12.1M in 2009) ** Q4
Slide 6: Fluid & Metering
Fluid & Metering Double digit growth...margins expanded 220 bps in 2010 6 2010 Sales Mix: Organic +13% Acquisition +2% Fx -1% Total +14% Progress in the Year: (+) Water - New products and regional expansion (-) Water - US Muni spend continues to be soft (+) Energy - Asia, Middle East and Latin Ameri
Slide 7: IDEX Pharma Build Out
IDEX Pharma Build Out Rise of Generics and new blockbuster drugs = pharma production increase Worldwide pharma growing 2x GDP "Pharmerging" growing 15%+ Continued build out of our Pharma platform in 2010 and 2011 Fitzpatrick and Microfluidics Complementary products with Quadro Synergies....sales for
Slide 8: Health & Science
Health & Science Record sales and profit; nearly 400 bps of margin expansion in 2010 8 2010 Sales Mix: Organic +21% Acquisition +10% Fx - Total +31% Progress in the Year: (+) Continued success with UHPLC (next gen) platforms (+) Gaining content on OEM platforms (+) New product launch into dental mar
Slide 9: Dispensing
Dispensing Completed large DIY project order; 2010 margins expanded on down sales 9 2010 Sales Mix: Organic Flat Acquisition - Fx -2% Total -2% Progress in the Year: (-) US and Western Europe markets continue to be soft (+) Asia and parts of Eastern Europe activity accelerating (+) Business remains
Slide 10: Fire & Safety
Fire & Safety Rescue gaining share, BAND-IT winning in new markets...near 24% Op Margin 10 2010 Sales Mix: Organic +2% Acquisition - Fx -1% Total +1% Progress in the Year: (+) eDraulic (next gen) rescue gaining traction, ahead of plan (+) International market growth (+) New applications expanding BA
Slide 11: Outlook: 2011 Guidance Detail
Outlook: 2011 Guidance Detail 11 Mid to High Single Digit Organic Sales Growth...12 - 17% EPS Growth 2011 Organic Growth Expectations Fluid and Metering Technologies - up mid to high single digits Health and Science Technologies - up near double digits Fire & Safety/Diversified - up mid to high sing
Slide 12: Outlook: 2011 Guidance Summary
Outlook: 2011 Guidance Summary Q1 2011 EPS estimate range: $0.52 - $0.54 Organic revenue growth of 5% - 7% Negative Fx impact of ~1% to sales (at Jan 31 rates) Positive impact of ~6% from acquisitions FY 2011 EPS estimate range: $2.23 - $2.33 Organic revenue growth in the mid to high single digits O
Slide 13: TEX roprietary &
&A TEX roprietary & Confidential